164 related articles for article (PubMed ID: 21471746)
21. Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy.
Pletz MW; Burkhardt O; Welte T
Eur J Med Res; 2010 Nov; 15(12):507-13. PubMed ID: 21163725
[TBL] [Abstract][Full Text] [Related]
22. Combination therapy with daptomycin, linezolid, and rifampin as treatment option for MRSA meningitis and bacteremia.
Kelesidis T; Humphries R; Ward K; Lewinski MA; Yang OO
Diagn Microbiol Infect Dis; 2011 Nov; 71(3):286-90. PubMed ID: 21855248
[TBL] [Abstract][Full Text] [Related]
23. Community-acquired methicillin-resistant Staphylococcus aureus infections.
Maltezou HC; Giamarellou H
Int J Antimicrob Agents; 2006 Feb; 27(2):87-96. PubMed ID: 16423509
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of linezolid-based salvage therapy compared with glycopeptide-based therapy in patients with persistent methicillin-resistant Staphylococcus aureus bacteremia.
Park HJ; Kim SH; Kim MJ; Lee YM; Park SY; Moon SM; Park KH; Chong YP; Lee SO; Choi SH; Woo JH; Kim YS
J Infect; 2012 Dec; 65(6):505-12. PubMed ID: 22902942
[TBL] [Abstract][Full Text] [Related]
25. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
Stein GE; Wells EM
Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750
[TBL] [Abstract][Full Text] [Related]
26. MRSA--too many hurdles to overcome: a study from Central India.
Mallick SK; Basak S
Trop Doct; 2010 Apr; 40(2):108-10. PubMed ID: 20305109
[TBL] [Abstract][Full Text] [Related]
27. Molecular characterization and antibiotic resistance of clinical isolates of methicillin-resistant Staphylococcus aureus obtained from Southeast of Iran (Kerman).
Sadeghi J; Mansouri S
APMIS; 2014 May; 122(5):405-11. PubMed ID: 24033803
[TBL] [Abstract][Full Text] [Related]
28.
Pfaller MA; Sader HS; Rhomberg PR; Flamm RK; Mendes RE
Microb Drug Resist; 2019; 25(6):938-943. PubMed ID: 30694735
[TBL] [Abstract][Full Text] [Related]
29. Management of methicillin-resistant Staphylococcus aureus pneumonia.
Luna CM; Boyeras Navarro ID
Curr Opin Infect Dis; 2010 Apr; 23(2):178-84. PubMed ID: 20075728
[TBL] [Abstract][Full Text] [Related]
30. [Staphylococcus aureus and antibiotic resistance].
Sancak B
Mikrobiyol Bul; 2011 Jul; 45(3):565-76. PubMed ID: 21935792
[TBL] [Abstract][Full Text] [Related]
31. [Successful treatment of life-threatening Panton-Valentine leucocidin positive Staphylococcus aureus pneumonia with antibiotics and immunoglobulins targeting the toxin production].
Libert N; Borne M; Janvier F; Batjom E; Cirodde A; Nizou JY; Brinquin L
Rev Med Interne; 2009 Oct; 30(10):907-10. PubMed ID: 19299049
[TBL] [Abstract][Full Text] [Related]
32. Limitations of antibiotic options for invasive infections caused by methicillin-resistant Staphylococcus aureus: is combination therapy the answer?
Nguyen HM; Graber CJ
J Antimicrob Chemother; 2010 Jan; 65(1):24-36. PubMed ID: 19861337
[TBL] [Abstract][Full Text] [Related]
33. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
[TBL] [Abstract][Full Text] [Related]
34. Empiric therapy directed against MRSA in patients admitted to the intensive care unit does not improve outcomes in community-acquired pneumonia.
Griffin AT; Peyrani P; Wiemken TL; Ramirez JA; Arnold FW
Infection; 2013 Apr; 41(2):517-23. PubMed ID: 23132663
[TBL] [Abstract][Full Text] [Related]
35. Community-acquired MRSA infections in North Carolina children: prevalence, antibiotic sensitivities, and risk factors.
Shapiro A; Raman S; Johnson M; Piehl M
N C Med J; 2009; 70(2):102-7. PubMed ID: 19489364
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis.
Champion EA; Miller MB; Popowitch EB; Hobbs MM; Saiman L; Muhlebach MS;
Pediatr Pulmonol; 2014 Mar; 49(3):230-7. PubMed ID: 23765686
[TBL] [Abstract][Full Text] [Related]
37. Low prevalence of Cfr-mediated linezolid resistance among methicillin-resistant Staphylococcus aureus in a Spanish hospital: case report on linezolid resistance acquired during linezolid therapy.
Sierra JM; Camoez M; Tubau F; Gasch O; Pujol M; Martin R; Domínguez MA
PLoS One; 2013; 8(3):e59215. PubMed ID: 23554998
[TBL] [Abstract][Full Text] [Related]
38. Effect of linezolid on clinical severity and pulmonary cytokines in a murine model of influenza A and Staphylococcus aureus coinfection.
Liu X; He Y; Xiao K; White JR; Fusco DN; Papanicolaou GA
PLoS One; 2013; 8(3):e57483. PubMed ID: 23478252
[TBL] [Abstract][Full Text] [Related]
39. Molecular characteristics of community-acquired methicillin-resistant Staphylococcus aureus in Hokkaido, northern main island of Japan: identification of sequence types 6 and 59 Panton-Valentine leucocidin-positive community-acquired methicillin-resistant Staphylococcus aureus.
Kawaguchiya M; Urushibara N; Kuwahara O; Ito M; Mise K; Kobayashi N
Microb Drug Resist; 2011 Jun; 17(2):241-50. PubMed ID: 21395449
[TBL] [Abstract][Full Text] [Related]
40. Pneumonia caused by methicillin-resistant Staphylococcus aureus.
Rubinstein E; Kollef MH; Nathwani D
Clin Infect Dis; 2008 Jun; 46 Suppl 5():S378-85. PubMed ID: 18462093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
